DocumentoJDRF Therapeutic Venturescargado por
sstrumello7395- DocumentoGeneral Foods Corporate Timelinecargado porsstrumello7395
- DocumentoJDRF, Less Until Nonecargado porsstrumello7395
- DocumentoWhy Big Pharmaceutical Companies’ Current Nanotech Efforts Should Failcargado porsstrumello7395
- DocumentoNovo Nordisk Congressional Testimony on Follow-On Biopharmaceuticals Mollerup March 26, 2007cargado porsstrumello7395
- DocumentoEmblem Insulin Formulary Change 2010cargado porsstrumello7395
- DocumentoWhy Nonprofits Fund For-Profit Companies Doing Drug Researchcargado porsstrumello7395
- DocumentoAgaMatrix & Sanofi-Aventis Enter Global Diabetes Partnershipcargado porsstrumello7395
- DocumentoHuman insulin prepared by recombinant DNA techniques and native human insulin interact identically with insulin receptorscargado porsstrumello7395
- DocumentoFDA ISO Standards for BG Meters 06-24-2009cargado porsstrumello7395
- DocumentoBeyond 'I'm a Diabetic', Little Common Groundcargado porsstrumello7395
- DocumentoHalozyme Therapeutics, Inc. 2009 Investor Day Presentationcargado porsstrumello7395
- DocumentoJDRF Countdown July 2009cargado porsstrumello7395
- Documento2008-03-24_Asset_EN Paper on Follow-On Biologics Jan. 2007cargado porsstrumello7395
- Documento2008-03-24_Asset_PCMA Summary of en Studycargado porsstrumello7395
- DocumentoInfluence of insulin antibodies on pharmacokinetics and bioavailability of recombinant human and highly purified beef insulins in insulin dependent diabeticscargado porsstrumello7395
- DocumentoThe Unique Cytoarchitechture of Human Pancreatic Islets Has Implications for Islet Cell Functioncargado porsstrumello7395
- DocumentoStatement of Inger Mollerup, VP Novo Nordisk A/S for Congressional Hearings on "Follow-On Biopharmaceuticals"cargado porsstrumello7395
- DocumentoMost Commercial Insulin Assays Fail to Detect Recombinant Insulin Analoguescargado porsstrumello7395
- DocumentoHow Do We Define Cure of Diabetes?cargado porsstrumello7395
- DocumentoExpanded T cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin isotopecargado porsstrumello7395
- DocumentoCould Generic Insulin Soon Hit the U.S. Market?cargado porsstrumello7395
- DocumentoClass Action Complaint for Negligence, Products Liability and Punitive Damages Against Eli Lilly & Company and Novo Nordisk A/S Re; Biosynthetic Human Insulincargado porsstrumello7395
- DocumentoMandated Diabetes Registries Will Not Benefit Persons With Diabetescargado porsstrumello7395
- DocumentoDetermination of Purity and Identification of Animal Sources of Insulin in Various Insulin Preparationscargado porsstrumello7395
- DocumentoPeter Van Etten JDRF Letter Recargado porsstrumello7395
- DocumentoTreatment of patients with new onset Type 1 diabetes with a single course of anti-CD3 mAb teplizumab preserves insulin production for up to 5 yearscargado porsstrumello7395
- DocumentoDifferent Potencies of Biosynthetic Human and Purified Porcine Insulincargado porsstrumello7395
- DocumentoQuestions Answers &cargado porsstrumello7395
- DocumentoStem Cells and Diabetescargado porsstrumello7395
- DocumentoFederal Funding of Stem Cell Researchcargado porsstrumello7395
Documentos de Académico
Documentos de Profesional
Documentos de Cultura
